- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Elranatamab, +19 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Elranatamab
Explore clinical trials studying Elranatamab. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Elranatamab trial results
Completed
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
NCT05228470
- Conditions
- BCMA, BCMA-CD3 Bispecific, Bispecific, +23 more
- Locations
-
- Fujian Medical University Union Hospital Fuzhou, Fujian, China
- Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
- Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China